Crescent Biopharma Inc. (CBIO)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 2,748,763 | $50,494,776 | 1.61% | |
| 2. | Balyasny Asset Management Dmitry Balyasny | 1,510,033 | $27,739,306 | +1252% | 0.04% |
| 3. | Vestal Point Capital Ryan Wilder | 1,500,000 | $27,555,000 | 0.77% | |
| 4. | Opaleye Management James A. Silverman | 1,312,615 | $24,112,738 | +12% | 3.18% |
| 5. | Tang Capital Management Kevin C. Tang | 1,160,000 | $21,309,200 | +33% | 1.08% |
Hedge Fund Resource Center